Next Article in Journal
Evaluation of Five Non-Culture-Based Methods for the Diagnosis of Meningeal Sporotrichosis
Next Article in Special Issue
Onychomycosis: Old and New
Previous Article in Journal
Bioclimatic Origin Shapes Phylogenetic Structure of Tirmania (Pezizaceae): New Species and New Record from North Africa
Previous Article in Special Issue
The Antidepressant Sertraline Affects Cell Signaling and Metabolism in Trichophyton rubrum
 
 
Article
Peer-Review Record

High Diversity of Fusarium Species in Onychomycosis: Clinical Presentations, Molecular Identification, and Antifungal Susceptibility

J. Fungi 2023, 9(5), 534; https://doi.org/10.3390/jof9050534
by Lai-Ying Lu 1,2,3, Jie-Hao Ou 4, Rosaline Chung-Yee Hui 1, Ya-Hui Chuang 1, Yun-Chen Fan 4 and Pei-Lun Sun 1,2,5,*
Reviewer 3:
J. Fungi 2023, 9(5), 534; https://doi.org/10.3390/jof9050534
Submission received: 14 March 2023 / Revised: 10 April 2023 / Accepted: 27 April 2023 / Published: 30 April 2023
(This article belongs to the Special Issue New Perspectives for Superficial Fungal Infections)

Round 1

Reviewer 1 Report

Globally, this work is good. The context, especially the clinical questions related to these molds misidentification, is clearly explained.

The references used are relevant and techniques used are adequate considering the objectives of the study.

Authors show the importance of identifying to which species or complexes of species a strain belongs, especially with regard to the levels of sensitivity to antifungal agents.

Several modifications are necessary:

Lines 56-57: The introduction would lack references for factors affecting epidemiological profiles.

 Line 72-79: Reference 8 is not valid for this section, I think the correct reference is 7. Please check that there are no other reference inversions in the document.

 Line 99: The reference article number 9 refers to the IQ-TREE phylogenetic package and not the DDJB.

 Line 103: I can't access the Fusarium Database (http://isolate.fusariumdb.org). Perhaps it’s due to a too restrictive setting of my university.

 Section 3.2: “chlamydospore-like swelling (Figure S1f)”   This is on figure 2f.

 Figure 2: In the legend, there is a typographical mistake, you write “chlamodospore”

 Section 3.4: “FSSC had a higher TRB MICs than non-FSSC.”, FSSC and FIESC although there is CLSI data for only one strain in this group.

 Section 3.6, case 2: “Molecular identification proved that all of them are F. keratoplasticum, but of three different genotypes based on the TEF-1α sequences (Figure 5d)”. This assertion is not supported by the quoted figure. Figure 5d show two genotypes only: One for CGMHD0862 and CGMHD1268 strains and one for CGMHD1078 strain like described in legend.

 In discussion, “PSO, TDO, and SWO phenotypes according to Uemura EVG et al, 24”: reference’s number is incorrectly dyctalographed.

Same remarks in this paragraph : “The MIC levels from North of Iran are compatible with our findings, as LLC and LNC was in the range of 1-0.001 μg/ml [25]. Based on Uemura EVG et al, MIC in Fusarium onychomycosis, ITC, FLC, and 5-Fluorocytosine showed high resistance tendency, TRB showed variable resistance tendency, and VRC and AMB showed low resistance tendency.24 The recently developed antifungal EFC has shown good treatment response in intractable cases [23 43], and olorofim has also shown promise as a candidate [44] after showing in vitro activity against FSSC and FOSC.”

 

You must verify all references because several problems were detected (references inversion, etc.).

 

Author Response

Please see the attachment. 

Author Response File: Author Response.pdf

Reviewer 2 Report

This is an interesting work, taking into account the many inconveniences that exist regading the NDM onychomycosis diagnosis.

Some parragraphs must be edited for better understanding.

Author Response

Please see the attachment. 

Author Response File: Author Response.pdf

Reviewer 3 Report

This is an interesting manuscript on Fusarium species in onychomycosis.  I advice to not report a table with all cases on onychomycosis (Table 1) but a unique summary table with location, duration, species, treatments, prognosis to make clear the presentation of data. 

Author Response

Please see the attachment. 

Author Response File: Author Response.pdf

Back to TopTop